Ignalis-M 50/500 Tablet ER
Ignalis-M 50/500 Tablet ER
Sitagliptin (50mg) + Metformin (500mg)
Macsita-MXR 50/500 Tablet
Macleods Pharmaceuticals Pvt Ltd
Sitagliptin 50mg
Pack Size
1 units
Price
Save ₹61
that's 41% off!
About This Medicine
Product description & overview
Ignalis-M 50/500 Tablet ER: Treating Type 2 Diabetes
Ignalis-M 50/500 Tablet ER is a once-daily oral tablet containing a fixed combination of Sitagliptin (50mg) and Metformin (500mg). This medication offers effective treatment for adults with type 2 diabetes, working to improve glycemic control by lowering blood sugar levels.
How it Works:
Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances the activity of incretin hormones, leading to increased insulin release and reduced glucose production in the liver. Metformin, on the other hand, acts by improving insulin sensitivity in cells, reducing glucose uptake in muscles, and decreasing hepatic glucose production.
Benefits:
* Improved Blood Sugar Control: Ignalis-M 50/500 helps manage blood sugar levels effectively, leading to better glycemic control.
* Convenient Once-Daily Dosage: The fixed combination formulation allows for a simple once-daily dosage for consistent treatment.
* Trusted and Established Medications: This medication is backed by robust clinical research and established use in managing type 2 diabetes.
Consult your healthcare professional before starting any new medication.
*Please note: This description is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional regarding your health concerns.*
Active composition
Metformin 500 mg
+1 more active ingredient
About Metformin
Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
All Active Ingredients
Sitagliptin
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Information regarding the use of Ignalis-M 50/500 Tablet ER during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
Ignalis-M 50/500 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
Ignalis-M 50/500 Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Ignalis-M 50/500 Tablet ER may be needed. Please consult your doctor. Use of Ignalis-M 50/500 Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
Breastfeeding
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Ignalis-M 50/500 Tablet ER is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Ignalis-M 50/500 Tablet ER